Non-Viral Drug Delivery Market Report and Forecast 2024-2032

Non-Viral Drug Delivery Market Overview

Non-viral drug delivery refers to methods that deliver therapeutic agents without using viruses to transport the drugs into cells. This approach includes techniques such as liposomes, nanoparticles, and polymer-based systems, offering a safer alternative to viral methods. It aims to enhance drug efficacy, targeting, and patient safety in treatment.

Non-Viral Drug Delivery Market Growth Drivers

Innovative Non-viral Drug Delivery Platforms to Drive Market Growth

Increasing demand for advanced drug delivery systems and the rising prevalence of age-related diseases are propelling market growth. In February 2024, PulseSight Therapeutics SAS, a new ophthalmology biotech company, secured seed funding from Pureos Bioventures and ND Capital. The company is developing a disruptive, minimally invasive non-viral gene delivery platform targeting age-related macular diseases (AMD), including geographic atrophy. This novel approach is set to impact the non-viral drug delivery market by providing more effective treatments for conditions affecting the elderly, driving market expansion in the forecast period.

Investment in Non-viral Drug Delivery to Meet Rising Non-Viral Drug Delivery Market Demand

The rising need for more targeted treatments and breakthroughs in nanotechnology fuels market growth in non-viral drug delivery. In May 2022, Sofinnova Partners invested EUR 3.5 million in NanoPhoria, a biotech firm working on a non-viral drug delivery platform based on inorganic nanoparticles. This investment aims to advance treatments for heart failure with reduced ejection fraction (HFrEF). As the platform progresses, it is poised to have a significant impact on the global non-viral drug delivery market, offering more efficient and precise therapies, and thereby fostering market development during the forecast period.

Non-Viral Drug Delivery Market Trends

Non-Viral Drug Delivery Market Segmentation

Non-Viral Drug Delivery Market Share

Market Share Based on Technology to Witness Substantial Growth

Nanoparticle drug delivery systems are expected to hold the largest market share in the market. This is due to their versatility, ability to target specific cells, and high efficiency in delivering drugs, particularly for cancer and chronic diseases. Nanoparticles can encapsulate a wide range of drugs, including poorly water-soluble compounds, and protect them from degradation in the body, ensuring sustained and controlled release. Additionally, advancements in nanotechnology are enhancing their effectiveness, improving drug bioavailability, and reducing side effects, making them a preferred choice in the pharmaceutical and biopharmaceutical sectors.

Non-Viral Drug Delivery Market Analysis by Region

North America leads the non-viral drug delivery market share, driven by its advanced healthcare infrastructure and high prevalence of chronic diseases. The region benefits from government support for healthcare advancements and the rapid adoption of cutting-edge technologies. The presence of major global biotechnology companies in the region also contributes significantly to its market share.

Leading Players in the Non-Viral Drug Delivery Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Moderna, Inc.

Moderna, Inc., founded in 2010 and headquartered in Cambridge, Massachusetts, USA, is a biotechnology company known for its pioneering mRNA-based therapies. Moderna’s portfolio in the non-viral drug delivery market primarily focuses on mRNA vaccines and therapeutics, including its COVID-19 vaccine. The company is also exploring the use of lipid nanoparticles (LNPs) for targeted mRNA delivery, a non-viral method to transport RNA into cells, making it a key player in advancing novel drug delivery systems for various diseases.

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc., established in 2002 and headquartered in Cambridge, Massachusetts, USA, is a gl...

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation, founded in 2002 and headquartered in Burnaby, British Columbia, Canada, is a bi...

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH, established in 1885 and headquartered in Ingelheim, Germany, is a glo...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Ionis Pharmaceuticals, Inc., CureVac N.V., Pfizer, Inc., Precision NanoSystems Inc., Cytiva Bioscience Holding Ltd., and Silence Therapeutics plc.

Key Questions Answered in the Non-Viral Drug Delivery Market

• What was the global non-viral drug delivery market value in 2023?
• What is the non-viral drug delivery market forecast outlook for 2024-2032?
• What is the market breakup based on the delivery method?
• What is the market breakup based on application?
• What is the market breakup based on technology?
• What is the market breakup based on the end user?
• What are the major factors aiding the non-viral drug delivery market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• Which country is expected to experience expedited growth during the forecast period?
• What are the major non-viral drug delivery market trends?
• Which delivery method will lead the market segment?
• Which application will lead the market segment?
• Which technology will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the non-viral drug delivery market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?